Inotek Pharmaceuticals Corporation Announces Closing of $79.2 Million Public Offering Including Exercise in Full of Underwriters’ Option to Purchase Additional Shares

LEXINGTON, Mass.--(BUSINESS WIRE)--ITEK Announces completion of $79 million offering

Full Story →